-
1
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
2
Evolving racial/ethnic disparities in AML survival in the novel therapy era
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
3
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
4
Optical genome mapping identified deletions, inversions, and insertions in hemophilia
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
5
CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
6
Loss of protein C vs protein S results in discrepant thrombotic phenotypes
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
7
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
8
Donor age contributes more to the rheological properties of stored red blood cells than donor sex and biological age distribution
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
9
Development and validation of predictive models of early immune effector cell–associated hematotoxicity
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
10
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
11
Cerebral vascular shunting and oxygen metabolism in sickle cell disease
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
12
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
13
Membrane-bound model of the ternary complex between factor VIIa/tissue factor and factor X
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
14
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
15
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
16
PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
17
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
18
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Published 2025-01-01“…Blood Advances…”
Get full text
Article -
19
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Published 2025-02-01“…Blood Advances…”
Get full text
Article -
20
PETAL: a global view on R/R T-/NK-lymphoma treatment reality
Published 2025-02-01“…Blood Advances…”
Get full text
Article